Over the last six months, Ocular Therapeutix’s shares have sunk to $10.44, producing a disappointing 7.4% loss - a stark ...

Ocular motor apraxia (OMA) is a neurological condition resulting in an inability to turn the eyes voluntarily in a horizontal manner. Ocular Motor Apraxia is known by a variety of terms. OMA is ...

Patients with psoriasis are at increased risk for cataracts, uveitis, dry eye disease, glaucoma, retinal vein occlusion (RVO) ...

Chronic rhinosinusitis (CRS) significantly affects ophthalmologic health but remains largely manageable, according to a ...

The world’s first dedicated hypotony clinic, funded by Moorfields Eye Charity, has been established at the Moorfields Eye ...

Signs and symptoms of ocular surface disease could be significantly reduced within 4 days after treatment with shelf-stable ...

Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli. The biotech, which is seeking to challenge Regeneron and ...

Ocular albinism (OA) is an inherited genetic condition that primarily affects the pigments in the eyes. Ocular albinism is an inherited genetic condition that primarily affects the pigments in the ...

Searching for effective treatment options for 'Ocular Hypertension symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

Exact presentation times may be subject to change. About Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. is a fully-integrated biopharmaceutical company committed to redefining the retina experience ...